NOVEL THERAPEUTICS TO TREAT NECROTIC TEETH: THE COMBINATORIAL EFFECT OF A 3D DRUG DELIVERY SYSTEM AND SPATIALLY DESIGNED STEM CELL NICHES
治疗坏死牙齿的新型疗法:3D 药物输送系统和空间设计的干细胞生态位的组合效应
基本信息
- 批准号:9755401
- 负责人:
- 金额:$ 35.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdhesionsAdolescentAffinityAgeAntibioticsApoptosisBacteriaBiological AssayBiophysicsBlood VesselsCanis familiarisCell SurvivalCellsChemicalsChildClinicalClinical TrialsCollagenCollagen FibrilConfocal MicroscopyCouples TherapyDataDentalDental PulpDental Pulp NecrosisDental cariesDentinDentin FormationDevelopmentDiagnostic radiologic examinationDisease modelDisinfectionDrug Delivery SystemsElectrospinningEncapsulatedEndodonticsEndotheliumEngineeringEnvironmentEvaluationExtracellular MatrixFutureGoalsGrowth FactorGrowth and Development functionHealthHemorrhageHistologicHistologyHumanImmunocompetenceImplantIn VitroInfectionInfection ControlInflammationInjectableInjectionsInjuryLeadLeftLocationMeasurementMediatingMethodsMicrobial BiofilmsMissionModelingMorphogenesisNanostructuresNational Institute of Dental and Craniofacial ResearchNatural regenerationNecrosisOdontoblastsOralOral healthPaste substancePatientsPeriapical DiseasesPlant RootsPolymersPopulationProceduresPropertyPublic HealthPulp CanalsRegulationReportingResearchRoleSchoolsSevere Combined ImmunodeficiencySliceSpatial DesignStandardizationStem cell transplantStem cellsSystemTherapeuticTimeTissuesTooth structureToxic effectTranslationsTraumaTubular formationVascular Endothelial Growth FactorsWorkantimicrobialbasebone morphogenetic protein 2cell behaviorchemical propertycombinatorialcraniofacialdeciduous toothexperienceimplantationimprovedin vivoin vivo ModelinnovationmRNA Expressionmouse modelnanofiberneovascularizationnovelnovel strategiesnovel therapeuticspatient variabilitypermanent toothphysical propertyprofessorprotein expressionregenerativeregenerative therapyrestorationstem cell differentiationsuccesstraditional therapy
项目摘要
Abstract/Summary:
Caries and dental trauma are major oral health burdens. Globally, 21% of children (age 6 to 11 years) have
caries in their permanent teeth. In the US, 18% of school children experience dental trauma. Dental pulp injury
due to caries or trauma, leads to inflammation, which if left untreated, results in necrosis. Traditional
therapeutics of necrotic immature permanent teeth allows for infection control, but support neither root
development nor restoration of the immunocompetence of the pulp. To date, no clinical therapy exists that
promotes root canal disinfection and can consistently guide the growth and development of pulp and dentin in
necrotic teeth. Thus, there is a pressing need to develop a strategy for predictable pulp-dentin regeneration in
a bacteria-free environment which may ultimately lead to the establishment of novel therapeutics to treat
immature teeth with pulpal necrosis. The objective of this application is to develop a novel strategy to stimulate
pulp and dentin regeneration by engineering an injectable collagen-fibril matrix system with heterogeneous
stiffness and selected growth factors (GFs), which will first require the attainment of a bacteria-free niche. Our
first hypothesis is that electrospinning can be used to develop non-toxic and antimicrobially effective 3D tubular
drug delivery constructs for root canal disinfection that release initially high amount of antibiotics and sustain its
effects for several days. The proposed construct will be evaluated for its release properties and cell
compatibility in vitro. Antimicrobial properties will be determined using an in vitro infected tooth slice model and
an in vivo model of immature dog teeth with periapical disease (Aim 1). Our second hypothesis is that dental
pulp stem cell transplantation within a stiffer collagen matrix added with bone morphogenetic protein-2 (BMP-2)
or within a more compliant matrix added with vascular endothelial growth factor (VEGF), when concentrically
injected into a disinfected root canal, will lead to dentin and pulp regeneration, respectively. We propose to
optimize the novel self-assembling collagen-fibril matrix system by evaluating the cell viability, proliferation,
apoptosis and differentiation to endothelial and odontoblast cells using in vitro cell-based assays and a well-
established in vivo tooth slice SCID mice model (Aim 2). Finally, the regenerative capacity of the optimal and
standardized injectable collagen-fibril matrix system will be evaluated using an in vivo model of immature dog
teeth with periapical disease after disinfection with the drug delivery construct (Aim 3). This application is
highly innovative as we propose, for the first time, the clinical role of a cell-friendly electrospun 3D tubular drug
delivery construct for root canal disinfection. Further, we propose to couple this therapy with a unique
regenerative strategy using injectable and highly tunable collagen-fibril matrices to amplify dental pulp stem
cell differentiation to form pulp and dentin in the appropriate locations. The proposed research is significant
because it will expedite the establishment of a reliable regenerative therapeutics to treat necrotic immature
permanent teeth.
摘要/总结:
龋齿和牙齿创伤是主要的口腔健康负担。全球21%的儿童(6至11岁)
他们的恒牙有龋齿。在美国,18%的学龄儿童经历过牙齿创伤。牙髓损伤
由于龋齿或创伤,导致炎症,如果不治疗,会导致坏死。传统
坏死的未成熟恒牙的治疗允许感染控制,但既不支持牙根
牙髓免疫活性的发育或恢复。迄今为止,没有临床治疗存在,
促进根管消毒,并能持续引导牙髓和牙本质的生长和发育,
坏死的牙齿因此,迫切需要开发一种可预测的牙髓牙本质再生策略,
一个无菌的环境,最终可能导致建立新的治疗方法来治疗
牙髓坏死的未成熟牙齿。本申请的目的是开发一种新的策略,以刺激
牙髓和牙本质再生的可注射胶原纤维基质系统工程与异质
硬度和选定的生长因子(GF),这将首先需要实现无菌生态位。我们
第一个假设是,静电纺丝可用于开发无毒和抗菌有效的3D管状
用于根管消毒的药物递送结构,
影响了几天。将评价拟定结构的释放特性和细胞
体外相容性将使用体外感染的牙齿切片模型来确定抗菌特性,
未成熟的狗牙齿与根尖周病的体内模型(目的1)。我们的第二个假设是
牙髓干细胞移植在加入骨形态发生蛋白-2(BMP-2)的硬胶原基质中
或在加入血管内皮生长因子(VEGF)的更柔顺的基质内,
注射到消毒的根管中,将分别导致牙本质和牙髓再生。我们建议
通过评价细胞活力,增殖,
凋亡和分化为内皮细胞和成牙本质细胞,
建立了牙片SCID小鼠体内模型(目的2)。最后,给出了最佳和最佳的再生容量,
将使用未成熟狗的体内模型评价标准化的可注射胶原-原纤维基质系统
用药物递送结构消毒后患有根尖周病的牙齿(目的3)。本申请是
高度创新,因为我们首次提出了细胞友好的静电纺丝3D管状药物的临床作用
用于根管消毒的递送构造。此外,我们建议将这种疗法与一种独特的
使用可注射和高度可调的胶原-原纤维基质扩增牙髓干的再生策略
细胞分化形成牙髓和牙本质的适当位置。所提出的研究是有意义的
因为它将加速建立一种可靠的再生疗法来治疗坏死的未成熟的
恒牙
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marco C Bottino其他文献
Marco C Bottino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marco C Bottino', 18)}}的其他基金
Personalized Strategies for Periodontal Tissue Regeneration - A Converged Biofabrication Approach
牙周组织再生的个性化策略——融合生物制造方法
- 批准号:
10390983 - 财政年份:2022
- 资助金额:
$ 35.14万 - 项目类别:
Personalized Strategies for Periodontal Tissue Regeneration - A Converged Biofabrication Approach
牙周组织再生的个性化策略——融合生物制造方法
- 批准号:
10668946 - 财政年份:2022
- 资助金额:
$ 35.14万 - 项目类别:
Combined bioprinting with stem cell technology to regenerate skin burn wounds
生物打印与干细胞技术相结合,使皮肤烧伤创面再生
- 批准号:
10645037 - 财政年份:2021
- 资助金额:
$ 35.14万 - 项目类别:
Combined bioprinting with stem cell technology to regenerate skin burn wounds
生物打印与干细胞技术相结合,使皮肤烧伤创面再生
- 批准号:
10447161 - 财政年份:2021
- 资助金额:
$ 35.14万 - 项目类别:
Combined bioprinting with stem cell technology to regenerate skin burn wounds
生物打印与干细胞技术相结合,使皮肤烧伤创面再生
- 批准号:
10315804 - 财政年份:2021
- 资助金额:
$ 35.14万 - 项目类别:
A Novel Multilayered Membrane for Periodontal Regeneration
用于牙周再生的新型多层膜
- 批准号:
9527438 - 财政年份:2017
- 资助金额:
$ 35.14万 - 项目类别:
NOVEL THERAPEUTICS TO TREAT NECROTIC TEETH: THE COMBINATORIAL EFFECT OF A 3D DRUG DELIVERY SYSTEM AND SPATIALLY DESIGNED STEM CELL NICHES
治疗坏死牙齿的新型疗法:3D 药物输送系统和空间设计的干细胞生态位的组合效应
- 批准号:
10231139 - 财政年份:2017
- 资助金额:
$ 35.14万 - 项目类别:
NOVEL THERAPEUTICS TO TREAT NECROTIC TEETH: THE COMBINATORIAL EFFECT OF A 3D DRUG DELIVERY SYSTEM AND SPATIALLY DESIGNED STEM CELL NICHES
治疗坏死牙齿的新型疗法:3D 药物输送系统和空间设计的干细胞生态位的组合效应
- 批准号:
9982298 - 财政年份:2017
- 资助金额:
$ 35.14万 - 项目类别:
A Novel Multilayered Membrane for Periodontal Regeneration
用于牙周再生的新型多层膜
- 批准号:
8879976 - 财政年份:2013
- 资助金额:
$ 35.14万 - 项目类别:
A Novel Multilayered Membrane for Periodontal Regeneration
用于牙周再生的新型多层膜
- 批准号:
8692736 - 财政年份:2013
- 资助金额:
$ 35.14万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 35.14万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 35.14万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 35.14万 - 项目类别: